Ascendis Pharma

ASND

Market cap $14.3B

Upgrade to unlock

Buy

Hold

Sell

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$287

23% upside

High target

8 analyst ratings

positive

0 neutral

0%

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Oppenheimer Leland Gershell 100% 1-yr ASND win rate				12 Feb ‘26 17 days ago
Wedbush Yun Zhong 100% 1-yr ASND win rate				12 Feb ‘26 17 days ago
BofA Securities Tazeen Ahmad 75% 1-yr ASND win rate				30 Jan ‘26 1 month ago
Barclays Eliana Merle 50% 1-yr ASND win rate				28 Jan ‘26 1 month ago
RBC Capital Luca Issi 100% 1-yr ASND win rate				20 Jan ‘26 1 month ago
Wells Fargo Derek Archila 67% 1-yr ASND win rate				20 Jan ‘26 1 month ago
TD Cowen Yaron Weber 100% 1-yr ASND win rate				7 Jan ‘26 1 month ago
Stifel Alex Thompson 100% 1-yr ASND win rate				11 Dec ‘25 2 months ago